Source:http://linkedlifedata.com/resource/pubmed/id/16399588
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Suppl 1
|
pubmed:dateCreated |
2006-1-9
|
pubmed:abstractText |
Hodgkin and Reed-Sternberg cells are derived from germinal center B cells. Amplification of identical rearranged and mutated immunoglobulin genes from different Hodgkin and Reed-Sternberg cells from the same patient also answered the question of the malignant nature because the clonality-the key criterion of malignancy-of Hodgkin and Reed-Sternberg cells was hereby shown. In addition, it could be demonstrated that Hodgkin and Reed-Sternberg cells do not only expand clonally within 1 affected lymph node, but also clonally disseminate in advanced-stage disease and relapse even after clinical complete remission. Recent publications demonstrate that a probably small subset of Hodgkin disease exists with T-cell derivation of the respective Hodgkin and Reed-Sternberg cells. The management of Hodgkin's disease is undergoing a paradigm shift as a result of very effective drug regimens that are capable of inducing high remission rates, the use of combined chemoradiotherapy with involved-field irradiation in early stages, the introduction of effective salvage chemotherapy of relapsed Hodgkin's disease with peripheral stem cell transplantation, a better understanding of prognostic factors, economic constraints, and a more sensitive realization of the magnitude of late treatment mortality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1083-8791
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
66-76
|
pubmed:meshHeading |
pubmed-meshheading:16399588-Combined Modality Therapy,
pubmed-meshheading:16399588-Disease-Free Survival,
pubmed-meshheading:16399588-Gene Rearrangement, B-Lymphocyte,
pubmed-meshheading:16399588-Germinal Center,
pubmed-meshheading:16399588-Hodgkin Disease,
pubmed-meshheading:16399588-Humans,
pubmed-meshheading:16399588-Mutation,
pubmed-meshheading:16399588-Prognosis,
pubmed-meshheading:16399588-Reed-Sternberg Cells,
pubmed-meshheading:16399588-Remission Induction,
pubmed-meshheading:16399588-T-Lymphocytes
|
pubmed:year |
2006
|
pubmed:articleTitle |
Advances in biology, diagnostics, and treatment of Hodgkin's disease.
|
pubmed:affiliation |
Institute for Cell Biology, Tumor Research, University of Duisburg-Essen, Germany.
|
pubmed:publicationType |
Journal Article,
Review
|